HIV-1 maturation inhibitor BMS-955176 demonstrates positive new Phase IIa results
22 July 2015 | By Victoria White
Bristol-Myers Squibb has announced additional Phase IIa data for BMS-955176, a novel investigational agent designed to prevent the maturation of HIV-1...